CLINICAL_TRIALS
trial_result
· 2021-04-14
Clinical Trial Update: Naltrexone and Clonidine Combination (ATNC05) in the Treatment of Chronic Back Pain [Phase 2]
Summary
Phase 2 trial update for a naltrexone and clonidine combination (ATNC05) in chronic back pain; study completed.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Annette C. Toledano MD | Conditions: Back Pain, Lower Back Pain | Phase 2 | Status: COMPLETED